Effects of different anesthesia methods on perioperative immune function in patients with hepatic cirrhosis

摘要

Objective:To investigate the effects of different anesthesia methods on perioperative immune function in patients with hepatic cirrhosis.Methods: Fifty cases of patients with hepatic cirrhosis who were included in our hospital from January 2011 to January 2012 received elective splenectomy devascularization under intubation and general anesthesia were selected and randomly divided into the treatment group and the control group, each group with 25 cases. The treatment group was given intravenous-inhalation combined anesthesia; the control group was given total intravenous anesthesia. Then immune function and recurrence rates of both groups were evaluated.Results: At T0 moment, CD3+, CD4+, CD8+, CD4+/CD8+ and NK cell numbers of both groups showed no statistical difference. Compared with those at T0, CD3+, CD4+, CD8+, CD4+/CD8+ and NK cell numbers of both groups at T1 moment significantly decreased; at T2 moment, CD3+, CD4+ and CD4+/CD8+ of treatment group were significantly higher than those of the control group. Overall study showed that the comparison between groups and time points as well as cross-comparison between two groups and time showed no significant difference. For the comparison between groups, at T0 moment, numbers of B lymphocytes showed no significant difference; the comparison of those at T1, T2 and T0 moment showed no significant difference, either. At T1, T2 and T0 moment, there were also no significant differences between groups. At T1 moment, INF-γ levels of both groups were lower than those at T0; there was restoration at T2 moment. At T1 moment, sIL-2R levels of both groups were lower than those at T0; there was slight restoration at T2 moment. For both groups, there were no significant differences at T1 and T2 moment. Recurrence rates and 5-year survival rates of two anesthesia methods showed no significant difference.Conclusion:Intravenous-inhalation combined anesthesia is helpful to restore cellular immune function of patients with hepatic cirrhosis and increase the safety of treatment; it is worthy of clinical application.